These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6148277)

  • 21. Preliminary report of treatment with oral contraceptive pills for intermenstrual vaginal bleeding secondary to a cesarean section scar.
    Tahara M; Shimizu T; Shimoura H
    Fertil Steril; 2006 Aug; 86(2):477-9. PubMed ID: 16769058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Infection hazards and complications following the use of IUDs].
    Böhm W; Seewald HJ; Voigt R; Süss C
    Zentralbl Gynakol; 1977; 99(24):1484-8. PubMed ID: 605704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Postmenopausal bleeding secondary to a Dalkon Shield retained for 33 years: a case report.
    Sozen I; Morgan K; Shannon JS
    J Reprod Med; 2005 Mar; 50(3):216-8. PubMed ID: 15841937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The copper IUD as an alternative to the "pill". Experiences with the intrauterine device Gyne-T].
    Heister VR
    Fortschr Med; 1977 Jan; 95(3):186-8. PubMed ID: 838420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tranexamic acid, intrauterine contraceptive devices and fatal cerebral arterial thrombosis. Case report.
    Agnelli G; Gresele P; De Cunto M; Gallai V; Nenci GG
    Br J Obstet Gynaecol; 1982 Aug; 89(8):681-2. PubMed ID: 7104262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hysteroscopic assessment of abnormal uterine bleeding in users of the intrauterine contraceptive device.
    Kulkarni S; Wynter HH; Desai P
    West Indian Med J; 1993 Sep; 42(3):124-5. PubMed ID: 8273322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Calcium lonazolac and blood loss in users of intrauterine devices. Preliminary report].
    Rubio Lotvin B; Ruíz Moreno JA; González Ansorena R; Ibarrola E; Uranga G; Benítez E
    Ginecol Obstet Mex; 1986 Aug; 54():221-4. PubMed ID: 3781294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Colposcopy in the localization of missing intrauterine devices.
    Anteby SO; Birkenfeld A
    Endoscopy; 1984 Jul; 16(4):146-8. PubMed ID: 6381034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical and biological experience with a new norsteroid: SH 513].
    Lévrier M
    Gynecol Prat; 1964; 15(1):29-36. PubMed ID: 5878723
    [No Abstract]   [Full Text] [Related]  

  • 30. Adrenosem therapy for bleeding coincident with the use of intrauterine contraceptive devices: a double blind study.
    Horne HW; Scott JM
    Fertil Steril; 1970 Mar; 21(3):230-3. PubMed ID: 4907971
    [No Abstract]   [Full Text] [Related]  

  • 31. [Oral contraceptives in the treatment of the meno-metrorrhagia of the solitary ovary syndrome after unilateral castration].
    Vasiliu V; Filipescu D
    Bull Fed Soc Gynecol Obstet Lang Fr; 1968; 20(5):Suppl:485-6. PubMed ID: 5759285
    [No Abstract]   [Full Text] [Related]  

  • 32. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
    Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
    Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Combined antihistaminic and vitamin treatment of certain skin diseases].
    ZANCHI M
    Rass Dermatol Sifilogr; 1955; 8(2):110-9. PubMed ID: 13267029
    [No Abstract]   [Full Text] [Related]  

  • 34. Factors affecting intrauterine contraceptive device performance. I. Endometrial cavity length.
    Hasson HM; Berger GS; Edelman DA
    Am J Obstet Gynecol; 1976 Dec; 126(8):973-81. PubMed ID: 998687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Problems of contraception].
    Rozenbaum H
    Concours Med; 1979 Jan; 101(2):207-8. PubMed ID: 759093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical evaluation of the therapeutic effectiveness of ethinyl oestradiol and oestrone sulphate on prolonged bleeding in women using depot medroxyprogesterone acetate for contraception. World Health Organization, Special Programme of Research, Development and Research Training in Human Reproduction, Task Force on Long-acting Systemic Agents for Fertility Regulation.
    Said S; Sadek W; Rocca M; Koetsawang S; Kirwat O; Piya-Anant M; Dusitsin N; Sethavanich S; Affandi B; Hadisaputra W; Kazi A; Ramos RM; d'Arcangues C; Belsey EM; Noonan E; Olayinka I; Pinol A
    Hum Reprod; 1996 Oct; 11 Suppl 2():1-13. PubMed ID: 8982739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Side effects of intrauterine devices.
    Connell EB
    Int J Gynaecol Obstet; 1977; 15(2):153-6. PubMed ID: 606586
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oestrogen treatment for increased bleeding in Norplant users: preliminary results.
    Witjaksono J; Lau TM; Affandi B; Rogers PA
    Hum Reprod; 1996 Oct; 11 Suppl 2():109-14. PubMed ID: 8982752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced vaginal bleeding in postmenopausal women who receive combined norethindrone acetate and low-dose ethinyl estradiol therapy versus combined conjugated equine estrogens and medroxyprogesterone acetate therapy.
    Simon JA; Liu JH; Speroff L; Shumel BS; Symons JP
    Am J Obstet Gynecol; 2003 Jan; 188(1):92-9. PubMed ID: 12548201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long term IUD user at menopause. The case of a woman who wore an IUD for 14 years.
    Smith DA
    S D J Med; 1987 Jan; 40(1):5-6. PubMed ID: 3468622
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.